Free shipping on all orders over $ 500

Abicipar pegol

Cat. No. M24615

All AbMole products are for research use only, cannot be used for human consumption.

Abicipar pegol Structure
Synonym:

AGN-150998; MP0112

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Abicipar pegol (AGN-150998, MP0112) is an anti-VEGF DARPin molecule, a novel class of small proteins containing ankyrin repeat domains engineered to bind with high specificity and affinity to target proteins. Abicipar pegol effectively inhibits angiogenesis and vascular permeability and is used in the study of diseases related to ocular inflammation by intravitreal injection, reducing mean retinal thickness and leakage area.

Chemical Information
CAS Number 1327278-94-3
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] Rehan M Hussain, et al. Expert Opin Biol Ther. Abicipar pegol for neovascular age-related macular degeneration

[2] Lorenzo Ferro Desideri, et al. Expert Opin Investig Drugs. Abicipar pegol: an investigational anti-VEGF agent for the treatment of wet age-related macular degeneration

[3] Claudio Campa. Curr Drug Targets. New Anti-VEGF Drυgs in Ophthalmology

[4] Ashish Sharma, et al. Eye (Lond). Abicipar pegol: the non-monoclonal antibody anti-VEGF

[5] Elad Moisseiev, et al. Eye (Lond). Abicipar pegol-a novel anti-VEGF therapy with a long duration of action

Related VEGFR/PDGFR Products
ABT-869

ABT-869 (Linifanib) is an ATP-competitive, multi-targeted RTK inhibitor that is completely effective against all members of VEGFR and PDGFR.

Tivozanib (AV-951)

Tivozanib (AV-951) is a potent VEGFR-1, 2 and 3, c-Kit and PDGFR inhibitor with IC50 of 0.21, 0.16, 0.24, 1.63 and 1.72 nM respectively.

Axitinib

Axitinib (AG013736) inhibits multiple targets including VEGFR, PDGFR and cKit.

Regorafenib

Regorafenib (BAY 73-4506) is a novel oral multikinase inhibitor of c-KIT, VEGFR2, B-Raf with IC50s of 17, 40 and 69 nM respectively.

Nintedanib

Nintedanib (BIBF1120) is a novel, potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: Abicipar pegol, AGN-150998; MP0112 supplier, VEGFR/PDGFR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.